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BACKGROUND/PURPOSE: The postweaning multisystemic wasting syndrome, caused by the porcine 
circovirus type 2 (PCV-2), is a major disease that poses a significant threat to the global swine industry. The 
purpose of this study was to establish a real-time polymerase chain reaction (PCR) method for the quanti-
fication of PCV-2 and to enable the rapid differentiation of porcine circoviruses type 1 and 2 (PCV-1 and 
PCV-2). Such a method would significantly speed up the process of clinical diagnosis, and could also be 
used to study the pathogenic mechanisms of diseases associated with PCV-2.
METHODS: Multiplex real-time PCR, together with LightCycler PCR data analysis software, was used 
for the quantification of PCV-2, and for the rapid differentiation of PCV-1 and PCV-2. A 263-bp DNA frag-
ment was amplified from the 3’ end of the open reading frame-2 of PCV-2 by nested PCR, and its DNA se-
quence was verified as having 100% identity with a PCV-2 standard (NCBI accession number: AF055394). 
The 263-bp DNA fragment was cloned into the pGEM-T easy vector, and the recombinant plasmid was 
serially diluted and quantified using real-time PCR. A standard curve was then constructed for quantifica-
tion of the PCV-2 levels in field samples. The differentiation of PCV-1 and PCV-2 was carried out by analyzing 
the melting temperatures of the genotype-specific PCR products.
RESULTS: To quantify the PCV-2 levels in field samples, a standard curve (1 × 102–1 × 109 copies/μL) was 
constructed. PCV-2 concentrations as low as 1 × 102 copies/μL could be detected in specimens taken from the 
lymph nodes or infected tissues in samples of PCV-2-infected pigs. The diagnosis of PCV-1 and PCV-2 in-
fections and the quantification of the viral load in the field samples could be completed within 45 minutes 
after extracting the viral DNA using a commercial extraction kit.
86
G.N. Chang, et al
Introduction
Porcine circovirus (PCV) was first identified by Tischer 
et al in 1974 as a non-cytopathic contaminant of the pig 
kidney cell line, PK-15 (ATCC CCL33), and was described 
as a Picornaviridae-like virus.1 In 1982, PCV was further 
characterized by Tischer’s group as a single stranded DNA 
virus with a circular genome having a diameter of about 
17 nm. Since it was originally detected in porcine cells, 
and its antibodies have been detected in pig sera, it was 
named porcine circovirus2 and was classified in 1993 by 
the International Committee on Taxonomy of Virus as a 
member of the virus family Circoviridae.
In 1986, Tischer et al utilized indirect immunofluores-
cence assays to determine the presence of porcine circovi-
rus type 1 (PCV-1) antibody in serum collected from pigs 
between 1979 and 1982 at different slaughterhouses in 
Germany, and reported a PCV-1 antibody-positivity rate 
of 77–95%.3
In 1991, the postweaning multisystemic wasting syn-
drome (PMWS) was first reported in Canada.4 The clinical 
signs of the disease include progressive weight loss and 
dyspnea. Gross pathologic findings associated with por-
cine circovirus type 2 (PCV-2) include granulomatous 
interstitial pneumonia, lymphadenopathy and, less fre-
quently, hepatitis and nephritis.5 Since 1991, PMWS in 
pigs has been reported in North America,6 Europe,7 and 
Asia.8 In the late 1990s, PCV was linked to PMWS.6,9
In 1995, Tischer et al used enzyme-linked immuno-
sorbent assays to recheck the presence of PCV-1 antibody 
in the serum of pigs from the different slaughterhouses 
in Germany and found that, while the PCV-1 antibody 
positive rate dropped to 35% overall, it was 95% in post-
partum sows, suggesting the accumulation of antibodies 
with increasing age.10
In 1999, Allan et al isolated PCV from tissues taken 
from PMWS-infected pigs from Spain, Denmark, and 
Northern Ireland, and determined their antigenicity by 
indirect immunofluorescence assays using polyclonal 
and monoclonal antibodies prepared against previously 
isolated PCVs.11 These PCV isolates were found to be both 
antigenically and genomically similar to previously re-
ported isolates of PCV from PMWS-infected pigs, but 
were distinct from the PCV isolates from the PK-15 cell 
lines. Sequence analysis of the PMWS-associated PCV 
revealed that it was antigenically and genomically differ-
ent from the earlier described PCV derived from persist-
ently infected PK-15 cell lines.12,13 The nonpathogenic 
type was designated as PCV-1 and the pathogenic PMWS-
associated PCV was designated as PCV-2. PCV-2 has been 
identified as the cause of PMWS.13,14
In 2000, Magar et al tested the serum of pigs collected in 
Canada in 1985, 1989, and 1997, and found an antibody-
positive rate of 28% for PCV-1 and 49% for PCV-2; con-
firming that both PCV-1 and PCV-2 existed as early as 
1985.15 In the same year, Allan et al extended the immun-
ofluorescence assays test to detect PCV-2 antibodies in 
the serum of cows, goats, and humans; however, the result 
was negative.16
Also in 2000, Larochelle et al detected PCV-2 DNA 
in boar semen using nested PCR after intranasal inocula-
tion of PCV-2. This suggests that PCV-2 can be transmit-
ted through semen.17 In the same year, Allan et al isolated 
the virus from aborted swine fetuses and stillborn pig-
lets, thus demonstrating vertical transmission of PCV-2 
from dam to piglet. Post-mortem examination revealed 
pathologic abnormalities such as congestive heart failure 
and diffuse myocarditis.16
In 2001, Sanchez et al inoculated PCV-2 into the uteri 
of sows, and demonstrated the ability of the virus 
to replicate in fetuses at different stages of gestation, and 
to cause pathologic abnormalities in fetuses including 
stillbirths.18
In 2002, Rovira et al tried to determine whether PMWS 
could be mimicked by inoculating healthy pigs with porcine 
reproductive and respiratory syndrome virus (PRRSV), 
PCV-2, or with both PRRSV and PCV-2.19 Inoculated pigs 
were subjected to histopathology, serology analysis, and 
CONCLUSION: This study demonstrate that real-time PCR is a clinically feasible method for the accu-
rate quantification of PCV-2, and for the rapid differentiation of PCV-1 and PCV-2.
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necropsy up to 32 days post-inoculation to detect the 
presence of antibodies and clinical signs of PMWS in the 
lesions. The techniques used for the detection of PCV-2 
and PRRSV included in situ hybridization, PCR, quantita-
tive PCR and reverse-transcription (RT)-PCR. They found 
that infection with PCV-2 subsequent to PRRSV infection 
might have caused immunosuppression, and potentiated 
the replication and distribution of the PCV-2 virus be-
cause more PCV-2 than expected was detected in the lung, 
liver, kidneys, and lymph nodes of the infected pigs. As a 
consequence, the virus nucleotide content was found to be 
much higher in the lesions of the PRRSV/PCV-2 infected 
pigs than that found in the lesions of PCV-2-infected pigs. 
Likewise, the symptoms of wasting and respiratory disease 
were more severe in the cases of PRRSV/PCV-2 infection.19
A variety of diagnostic tests for PCV-2 were recently 
reviewed by Opriessnig et al.20 Conventional methods 
used for detecting PCV-2 in cases of co-infection include 
in situ hybridization,14,21,22 which is complex and time-
consuming, and antibody-based immunohistochemistry 
methods,23 which are also time consuming. Neither is as 
sensitive as molecular diagnostic methods, such as PCR 
for post-mortem specimens.
Most of the reported real-time PCR methods were used 
in cases where PCV-2 was the only virus present,24,25 or 
where PCV-2 was co-infected with either porcine par-
vovirus,26,27 or PRRSV.28
Fenaux et al reported the differentiation of PCV-1 and 
PCV-2 using a universal PCR-restriction fragment length 
polymorphism (PCR-RFLP) diagnostic assay.6 This method 
requires restriction enzyme digestion analysis following 
the conventional PCR amplification of the PCV-1 or PCV-
2-specific DNA fragments.
Larochelle et al used multiplex PCR to differentiate 
PCV-1 and PCV-2.29 This method operates on the same 
principle as ours, except that a 349-bp PCV-1-specific DNA 
fragment (as opposed to our 74-bp fragment) was ampli-
fied, and that gel electrophoresis was used to differentiate 
the PCV-specific PCR products.
The possibility of mixed infection with PCV-1 and 
PCV-2 has already been reported30 (and is common on pig 
farms in Taiwan), as has the concurrent presence of 
both PCV-1 and PCV-2 in the same herd.31 Therefore, it is 
necessary to develop a fast and direct method for the 
simultaneous detection and differentiation of PCV-1 
and PCV-2 to avoid erroneous diagnosis during epidemio-
logical outbreaks. Therefore, the aim of this study was to 
develop an improved multiplex real-time PCR method for 
the rapid diagnosis and differentiation of PCV-1 and 
PCV-2 in cases of co-infection.
Methods
Extraction of viral DNA
Viral DNA was extracted from homogenates of clinical 
tissue samples using the “High Pure” Viral Nucleic Acid 
Kit (Roche Diagnostics, Mannheim, Germany) according 
to the manufacturer’s instructions.
PCR primers
Primers were designed using the Universal Probe Library 
software (Roche Diagnostics). For PCV-1, primers UPL-F: 
5-GTG GCG GGA GGA GTA GTT AAT-3 (1,277–
1,297 bp) and UPL-R: 5-TCT TGG ATG CCA ACT TTG 
TAA C-3 (1,350–1,329 bp) were used and these primers 
were designed to amplify a 74-bp PCV-1-specific DNA 
fragment from standard PCV-1 (PK15 cell line; ATCC 
CCL33). A locked nucleic acid probe #22: 5-TGG TGG 
AG-3 (1,318–1,325 bp), which responded positively only 
to PCV-1, was also included to test the PCV-1-specificity 
of the selected primers. For PCV-2, primers 263F: 5-TAG 
GTT AGG GCT GTG GCC TT-3 (1,323–1,342 bp) and 
263R: 5-CCG CAC CTT CGG ATA TAT ACT G-3 (1,586–
1,567 bp) were used. These primers were designed to am-
plify a 263-bp PCV-2-specific DNA fragment, which was 
selected from the PCV-2 open reading frame-2 region.19 
A locked nucleic acid probe #79: 5-CCA GGA GG-3 
(537–544 bp), which responded positively only to PCV-2, 
was also included to test the PCV-2-specificity of the se-
lected primers. PCV-2 from strain NPUST-2K132 was used 
to establish a standard curve.
The PCR product was subjected to DNA sequencing and 
compared with the DNA sequence of PCV-1 and PCV-2 
deposited in NCBI (accession number: AY193712 and 
AF055394, respectively) to confirm the specificity of PCR.
Establishment of a standard curve for PCV-2 
quantification
The 263-bp PCV-2-specific DNA fragment was amplified 
and inserted into the pGEM-T easy vector to obtain 
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the recombinant plasmid. To ensure that the 263-bp 
DNA fragment was correctly inserted, the recombinant 
plasmid was digested with EcoRI and then electro-
phoresed on an agarose gel to confirm the presence of 
DNA insert. The cloned plasmid was then sequenced 
and compared with that of NCBI (accession number: 
AF055394).
A standard curve, relating the PCR cycle number as a 
function of the viral DNA concentration, was constructed 
by serial dilution of the plasmid containing the 263-bp 
DNA insert, and each dilution was quantified using real-
time quantitative PCR and used as the copy reference to 
construct the standard curve (1 × 102–1 × 109 copies/μL) 
for the quantification of PCV-2 levels in field samples. 
The DNA concentration was determined by optical 
density at 260 nm and converted into copies per mole 
as described.33
Real time quantitative PCR
Quantification of PCV-1 and PCV-2
Real-time PCR was performed using the LightCycler 
FastStart DNA Master SYBR® Green I kit (Roche Diag-
nostics).The amplification was carried out in a 20 μL re-
action containing 1 μM of each forward and reverse 
primer, 3 mM Mg2+, 2 μL of 1 × Master SYBR Green I Mix 
(Roche Diagnostics) and 5 μL DNA template (NPUST 
2K1). The PCR conditions were as follows: 95ºC for 10 
minutes, followed by 30 cycles of amplification at 95ºC 
for 0 seconds, 62ºC for 5 seconds and 72ºC for 11 seconds. 
Melt curve analysis was performed at 95ºC for 0 seconds, 
65ºC for 15 seconds and 95ºC for 0 seconds; and cooling 
at 40ºC for 30 seconds.
For the quantification of PCV-2 concentrations in 
field specimens, viral DNA was extracted from the lymph 
nodes of PCV-2-infected pigs, and the PCV-2-specific 
DNA fragments were amplified by real-time PCR using 
the PCV-2-specific primer pair. The PCV-2 concentration 
(virus copies/μL) was quantified by cor relation with the 
standard curve.
The same PCR conditions were used for the quantifi-
cation and identification of unknown PCV-1 in sample 
tissues, except PCV-1-specific UPL-F and UPL-R primers 
and a DNA template extracted from the standard PCV-1 
(PK15, ATCC CCL33) were used.
Differentiation of unknown PCV in tissue samples
To differentiate PCV-1 from PCV-2, we used a multiplex 
PCR protocol, which enables the simultaneous amplifica-
tion of more than one target sequence in a single PCR 
step using two pairs of primers. The LightCycler software 
(Roche Diagnostics) for PCR data analysis was used to de-
termine the characteristic melting temperature (Tm) of 
the PCR products obtained from standard PCV-1 (PK15, 
ATCC CCL33), PCV-2 (NPUST-2K1 strain) and PCVs of 
unknown type.
Results
The melting curve analysis results from the genotyping 
of 10 field samples showed that the melting temperatures 
of PCV-1 and PCV-2 PCR products were 82.54 ± 0.15ºC 
and 86.15 ± 0.17ºC, respectively (Table). The melting curve 
is shown in Figure 1. A difference of about 3.6ºC between 
the two melting temperatures amplified by multiplex real-
time PCR procedure is evident. This suggests that real-
time PCR is a reliable method for the discrimination of 
PCV-1 from PCV-2.
Figure 2 shows the change in fluorescence with in-
creasing PCR cycle number when PCV-2-specific primers 
were used. Since only PCV-2-positive samples show an in-
crease in fluorescence during the PCR reaction, the effi-
ciency and specificity of PCV-2-specific primers is clear.
Figure 3 shows the typical change in fluorescence with 
increasing PCR cycle number when PCV-1 specific prim-
ers were used. Likewise, as only the PCV-1-positive sam-
ples show an increase in fluorescence during the PCR, the 
efficiency and specificity of PCV-1-specific primers is clear.
Table. Result of genotyping by melting temperature analysis 
for porcine circovirus type 1 and type 2 sample amplified by 
multiplex real-time polymerase chain reaction (n = 10)*
Primers 
Tm (ºC) Tm difference
 PCV-1 PCV-2 (ºC)
UPL-F & UPL-R 82.54 ± 0.15 – 3.61 ± 0.18
263F & 263R – 86.15 ± 0.17
*Data presented as mean ± standard deviation. Tm = Melting 
temperature; PCV-1 = porcine circovirus type 1; PCV-2 = porcine 
circovirus type 2.
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Figure 1. Comparison of the melting curves between multiplex 
real-time polymerase chain reaction-amplified porcine circovirus 
type 1- and type 2-specific fragments show a 3.6ºC difference in 
their melting temperatures. Blue traces, positive control for 
PCV-1 (Tm = 82.54ºC); green traces, positive control for PCV-2 
(Tm = 86.15ºC); red traces, a field sample whose melting curve 
appeared in the same melting range as the positive control for 
PCV-2; black and pink traces, the negative controls for PCV-1 
and PCV-2, respectively.
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Figure 2. Fluorescent signal for both the field and standard 
samples of porcine circovirus type-1 and type-2 after real-time 
polymerase chain reaction using PCV-2-specific primers 263F 
and 263R, together with locked nucleic acid probe #79, which 
responded positively only to PCV-2. The result indicates that only 
PCV-2 responded positively. Blue trace, standard PCV-1 refer-
ence (PK15, ATCC CCL33); green trace, standard PCV-2 refer-
ence (NPUST-2K1); red trace, negative control (H2O).
viral concentration of PCV-2 as low as 102 copies/μL was 
detected, indicating the sensitivity of this method for 
PCV-2 quantification.
When the standard PCV-2 plasmid was used to evalu-
ate the reproducibility of our real-time PCR for PCV-2, 
the intra- and inter-assay coefficients of variation for the 
PCR threshold cycle (CT) values were found to range 
between 1.00–1.64%, and 1.16–1.83%, respectively.
Figure 5 shows the PCR amplification plot of a field 
sample of PCV-2, together with a positive control. The 
viral load of the field specimen was found to be 3.1 × 
106 copies/μL according to the standard curve established 
in Figure 4.
Discussion
The purpose of this study was to establish a real-time 
PCR method for the quantification of PCV-2, and for the 
rapid differentiation of PCV-1 and PCV-2 in order to 
speed up the process of clinical diagnosis. A conventional 
diagnostic procedure for PCV-2 takes about 7–8 hours 
and involves PCR, nested PCR, and agarose gel electro-
phoresis. In comparison, our real-time PCR method takes 
about 45 minutes and has great potential as a practical 
tool for clinical diagnosis.
The PCR-RFLP assay developed by Fenaux et al to dif-
ferentiate PCV-1 and PCV-2 identified two fragments 
Figure 4 shows the individual fluorescent signals 
of each dilution of plasmid DNA (263-bp fragment) dur-
ing real-time PCR and the standard curve constructed 
from these individual runs. The DNA sequence of the 
263-bp fragment was found to have 100% identity when 
compared with that of the PCV-2 standard (accession 
number: AF055394). As expected, a good linear relation-
ship between the threshold PCR cycle number and the 
logarithmic DNA concentration was obtained, since the 
concentration of viral DNA was exponentially multiplied 
during PCR amplification. It is worth mentioning that a 
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Figure 3. Fluorescent signal for field and standard samples of 
porcine circovirus type 1 and type-2 after real-time polymerase 
chain reaction using the PCV-1-specific primers UPL-F and UPL-R, 
together with locked nucleic acid probe #22, which responded 
positively only to PCV-1. The result indicates that only PCV-1 
responded positively. Blue trace, standard PCV-1 reference (PK15 
ATCC CCL33); green trace, PCV-1 field sample; red trace, stand-
ard PCV-2 reference (NPUST-2K1); black trace, PCV-2 field sample; 
pink trace, negative control (H2O).
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(168 bp and 75 bp) from the amplified PCV-2 isolates, and 
one fragment of 243 bp from PCV-1 isolates.6 In clinical 
samples from pigs with dual infection by PCV-1 and PCV-2, 
all three fragments (243, 168, and 75 bp) were detected, 
indicating the reliability of the method for use in the dual 
infection cases. In comparison, our method requires only 
one multiplex real-time PCR procedure to accurately dif-
ferentiate PCV-1 and PCV-2, and is relatively time-saving. 
The Larochelle also used multiplex PCR method,29 but 
used gel electrophoresis to differentiate the PCV-specific 
PCR products by their molecular size. In comparison, our 
method takes advantage of the built-in melting curve anal-
ysis function of the PCR instrument to differentiate PCV-1 
PCR product from the PCV-2 PCR product, and consider-
ably shortens the time required for the PCV typing step.
For the quantification of PCV-2 levels in field samples, 
a 263-bp DNA fragment was amplified from the 3 end of 
the open reading frame-2 of the PCV-2 standard by nested 
PCR, and its DNA sequence was verified by comparison 
with that of NCBI. The recombinant plasmid containing 
the 263-bp insert from PCV-2 was serially diluted, and 
quantified using real-time PCR to construct a standard 
curve. For field sample quantification, PCV-2 concentra-
tions as low as 1 × 102 copies/μL were detectable in speci-
mens taken from the lymph nodes or infected tissues of 
PCV2-infected pigs.
Since SYBR Green I stains any double-stranded DNA, 
the PCR incorporated both positive and negative controls, 
and the Tm of the PCR products was also analyzed to rule 
out contamination.
This rapid PCV-2 quantification method can also be 
used for the determination of the PCV-2 levels in serum 
as an indicator of viremia; the early detection of PCV-2-
associated diseases such as PMWS (since PCR is sensitive 
enough to detect small amounts of viral DNA in tissues 
and organs); for the post vaccination tracking of the viral 
load in different tissues and organs of pigs in pathogene-
sis studies; and for evaluating the potency of developmen-
tal vaccines.
Several research groups have reported detection of 
PCV-2 and PRRSV in the same tissues of co-infected pigs 
by PCR, and that PCV-2 DNA was most prevalent in 
monocyte/macrophages within the lymphoid tissues.8,11,34 
Thus, in the future application of our PCV-2 test for de-
tecting PCV-2 related diseases in pigs, we recommend 
sampling the monocyte/macrophage cells in the blood or 
lymphoid tissues as the first priority.
Overall, this study shows that real-time PCR is a clinically 
feasible method for the accurate quantification of PCV-2, 
and for the rapid differentiation of PCV-1 and PCV-2.
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Figure 4. (A) Fluorescent signals during real-time polymerase 
chain reaction for each serial dilution of plasmid DNA (263 bp 
fragment; 1 × 102–1 × 109 copies/μL), and (B) the standard curve 
established for these individual runs.
Figure 5. (A) Amplification plot of the real-time polymerase 
chain reaction-amplified positive control (left curve) and field 
sample (right curve) of viral DNA taken from the lymph nodes of 
porcine circovirus (PCV) type-2-infected pigs. (B) The cross point 
at the standard curve quantified the viral load of field sample as 
3.1 × 106 copies/μL.
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